Introduction
In addition to their essential role in the process of haemostasis, platelets contribute to immune responses through several mechanisms including the interaction of surface receptors with invading pathogens. Human platelets express the low affinity receptor for immunoglobulin G, FcγRIIa (CD32a), which recognizes the immunoglobulin G (IgG) that opsonizes invading pathogens in the circulation.
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Abstract
Platelets express key receptors of the innate immune system such as FcγRIIa and Toll-like receptors (TLR). P2X1 cation channels amplify the platelet responses to several major platelet stimuli, particularly glycoprotein (GP)VI and TLR2/1, whereas their contribution to Src tyrosine kinase-dependent FcγRIIa receptors remains unknown. We investigated the role of P2X1 receptors during activation of FcγRIIa in human platelets, following stimulation by cross-linking of an anti-FcγRIIa monoclonal antibody (mAb) IV.3, or bacterial stimulation with Streptococcus sanguinis. Activation was assessed in washed platelet suspensions via measurement of intracellular Ca 2þ ([Ca 2þ ] i ) increases, ATP release and aggregation. P2X1 activity was abolished by pre-addition of α,β-meATP, exclusion of apyrase or the antagonist NF449. FcγRIIa activation evoked a robust increase in [Ca 2þ ] i (441 AE 33 nM at 30 μg/mL mAb), which was reduced to a similar extent (to 66-70% of control) by NF449, pre-exposure to α,β-meATP or apyrase omission, demonstrating a significant P2X1 receptor contribution. FcγRIIa activation-dependent P2X1 responses were partially resistant to nitric oxide (NO), but abrogated by 500 nM prostacyclin (PGI 2 ). Aggregation responses to bacteria and FcγRIIa activation were also inhibited by P2X1 receptor desensitization (to 66 and 42% of control, respectively). However, FcγRIIa-mediated tyrosine phosphorylation and ATP release were not significantly altered by the loss of P2X1 activity. In conclusion, we show that P2X1 receptors enhance platelet FcγRIIa receptor-evoked aggregation through an increase in [Ca 2þ ] i downstream of the initial tyrosine phosphorylation events and early dense granule release. This represents a further route whereby ATP-gated cation channels can contribute to platelet-dependent immune responses in vivo.
results in the activation of a signal transduction pathway through an immunoreceptor tyrosine-based activation motif (ITAM) in a manner similar to that observed following stimulation of the collagen and fibrin receptor GPVI. 2 The vital role of FcγRIIa receptor in platelet aggregation and thrombus formation has been established by several in vitro and in vivo studies. [3] [4] [5] In addition, interaction between bacteria and platelets has been shown to cause formation of dangerous circulating or localized thrombi such as in infective endocarditis (IE). 6 Despite this, our knowledge of FcγRIIa receptor involvement in platelet function remains rudimentary. P2X1 channels are the only adenosine triphosphate (ATP)-activated receptors in platelets and represent the fastest Ca 2þ entry route following ATP release from an injury site. 7 The contribution of P2X1 channels to thrombosis in vivo, and their important role in primary and secondary agonist-induced platelet activation, has been described previously. P2X1 activity linked to the activation of both TLRs and GPVI was found to persist when endothelium-derived inhibitory molecules such as NO and prostacyclin (PGI 2 ) were present in the extracellular milieu, highlighting the unique contribution of this ligand-gated cation channel to thrombosis and its potential as a drug target. 10 The ability of P2X1 receptors to contribute so efficiently to platelet responses likely results from their rapid activation mechanism and predominantly autocrine stimulation by ATP released from dense granules. 8 However, it is unknown whether this contribution of P2X1 receptors to GPVI and TLR2/1 responses modifies the early tyrosine kinase-dependent steps. Furthermore, the relative importance of P2X1 channels to FcγRIIa receptor platelet signalling and downstream responses is unknown.
In the present study, we provide evidence that human platelet P2X1 receptors contribute to the [Ca 2þ ] i increase and aggregation following FcγRIIa receptor activation achieved by receptor cross-linking using selective antibodies or Streptococcus sanguinis 133-79. 5, 13 This amplification of FcγRIIa receptor-evoked Ca 2þ increases by P2X1 persists in the presence of high levels of the ectonucleotidase apyrase and nitric oxide (NO) and thus provides a mechanism whereby Ca 2þ entry may be stimulated by antibody complexes or opsonized bacteria in the intact circulation.
Materials and Methods

Reagents
Anti-FcγRIIa monoclonal antibody (mAb) IV.3 was purified in the laboratory from a hybridoma. Goat anti-mouse IgG F(ab′) 2 was purchased from Fisher Scientific (UK). Apyrase (grade VII) from potato, a form of ecto-nucleoside triphosphate diphosphohydrolase (NTPDase), which displays similar properties to human CD39, 14 was from Sigma-Aldrich (Poole, UK 
Bacterial Culture and Preparation
Streptococcus sanguinis 133-79 was provided by Prof Mark Herzberg (University of Minnesota). Bacteria were cultured under anaerobic conditions at 37°C overnight and suspensions were prepared as previously described. 15 After washing in phosphate-buffered saline (PBS), the optical density of the suspension was adjusted to 1.6 at a wavelength of 600 nm, which corresponds to 6 Â 10 8 CFU/mL as previously shown. Aggregation of washed platelet suspensions was assessed by standard light transmission measurements, with simultaneous luminescence measurements of ATP secretion as required, in a Chrono-Log 400 Lumi-Aggregometer (ChronoLog Corporation), at 37°C as described in detail elsewhere.
8,14
100 μg/mL fibrinogen and 2 mM CaCl 2 were added to the cuvette at the start of each experiment. For each batch of luciferin-luciferase, a concentration-response curve across a range of known ATP concentrations (nM) was constructed using the background-corrected peak signal (mV) detected in normal platelet saline containing 0.32 U/mL apyrase (to mimic the conditions used to assess platelet-dependent ATP release).
Protein Phosphorylation
Protein lysates were prepared from 500 μL samples of stirred platelet suspensions, which were pretreated with 9 μM eptifibatide to prevent aggregation. Lysis was achieved by addition of an equal volume of ice-cold 2 Â radioimmunoprecipitation assay (RIPA) buffer (including 1Â Roche protease inhibitor tablet, 4 mM sodium orthovanadate and 20 mM sodium fluoride) 60 seconds after FcγRIIa cross-linking using IgG F (ab′) 2 (15 μg/mL). Protein quantification was performed with a Bradford assay. Tyrosine phosphorylation was detected by Western blotting with anti-phosphotyrosine (clone 4G10; 1:1,000), phospho-Syk (Tyr 525/526; 1:500), phospho-LAT (Tyr 200; 1:1,000) and phospho-PLCγ2 (Tyr 1217; 1:250) antibodies. Membranes were re-probed with a pan-anti-PLCγ2 antibody (1:200). Lysate (20 μg) was added in each well of a 12-well Bolt 4 to 12% Bis-Tris Plus Gel (Invitrogen, Paisley, UK). Each gel included at least one lane of 10 μL of Color Prestained Protein Standard (11-245 kDa; NEB, Ipswich, Massachusetts, United States). Gels were run at 100V for 90 minutes and semi-dry transfers onto PVDF membranes were performed using a Trans-Blot Turbo Transfer Imaging System (Bio-Rad, Hertfordshire, UK). Bands were visualized using horseradish peroxidase (HRP)-conjugated secondary antibodies and an ECL Prime kit (GE Healthcare, Buckinghamshire, UK) according to the manufacturer's instructions. The membranes were placed in a hyperfilm cassette, and hyperfilms (GE Healthcare) were exposed to the membranes in a dark room. Films were developed in a hyperfilm processor and scanned for analysis.
Statistical Analysis
All traces are representative of experiments from at least three separate donors. Average results have been expressed as means AE standard error of the mean (SEM).
All statistical analyses were performed on GraphPad Prism ] i increase (►Fig. 1 C, E). The average peak FcγRIIa receptor-evoked responses were reduced to 303 AE 31 nM (69% of control; p < 0.05, n ¼ 3) by NF449; 307 AE 42 nM (70% of control; p < 0.05, n ¼ 3) without apyrase; and 291 AE 40 nM (66% of control; p < 0.05, n ¼ 3) after pre-addition of 600 nM α,β-meATP (by one-way ANOVA, followed by Holm-Sidak's post hoc multiple comparisons). A further reduction of FcγRIIa receptor-evoked responses (to 191 AE 30 nM; 44% of control; p < 0.05, n ¼ 3, by one-way ANOVA, followed by Holm-Sidak's post hoc multiple comparisons) was observed in nominally Ca 2þ -free saline, indicating that other Ca 2þ entry pathways such as store-operated Orai1 channels or TRPC6 also contribute (►Fig. 1 D, E). As used previously for GPVI and TLR2/1 receptors, 8, 10 subsequent experiments used pre-addition of 600 nM α,β-meATP to selectively abrogate P2X1 activity, as it is slightly more effective than 1 μM NF449 and small effects on P2Y receptors have been reported for higher NF449 concentrations or omission of apyrase.
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The relative contribution of P2X1 receptors to collagenevoked Ca 2þ responses compared with other pathways is greater at low compared with high levels of stimulation, ranging from approximately 45 to 92%, across a 10-fold concentration of agonist. 8, 18 P2X1 receptors contributed significantly across the entire range of IgG F(ab′) 2 concentrations tested (►Fig. 2 A-F), with desensitization resulting in a reduction to 71% of control at 30 μg/mL; 67% of control at 15 μg/mL IgG F(ab′) 2 ; 62% of control at 7.5 μg/mL IgG F(ab′) 2 and 65% of control at 3.75 μg/mL IgG F(ab′) 2 (using two-way ANOVA, followed by Bonferroni's multiple comparisons tests). Although the largest P2X1 receptor contribution was observed at the intermediate concentrations of IgG F(ab′) 2 (►Fig. 2 C, D, F), the response was very weak in some donors at or below 7.5 μg/mL. Therefore, 15 μg/mL was selected as a consistent stimulus for further assessment of the contribution of P2X1 receptors to FcγRIIa receptor signalling and function. , and addition of α,β-meATP (600 nM) 90 seconds prior to IgG F(ab′) 2 were studied. 
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This was unexpected since both GPVI and FcγRIIa signal through an ITAM-dependent pathway. The collagen-dependent stimulation of P2X1 receptors persists in high PGI 2 due to a partial resistance of GPVI-evoked dense granule secretion to elevated cyclic AMP. 10, 20 In contrast, FcγRIIa-induced ATP release was completely blocked by 500 nM PGI 2 , thus Role for P2X1 in FcγRIIa Signalling Ilkan et al. 373
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Streptococcus sanguinis
Amplification of FcγRIIa Receptor Responses Is Independent of Initial Tyrosine Phosphorylation Events
In addition to direct effects of Ca 2þ influx on functional events, we also considered the possibility that P2X1 receptors may enhance FcγRIIa receptor-induced responses through modulation of early tyrosine phosphorylation events. FcγRIIa-induced tyrosine phosphorylation was assessed across all sites using a pan-phosphotyrosine antibody (4G10) along with phosphorylation of specific targets using phospho-specific antibodies Discussion ATP-gated P2X1 channels are the only ligand-gated Ca 2þ -permeable ion channels conclusively shown to be expressed on the platelet surface and provide a rapid route for Ca 2þ entry ] i responses observed in vitro following stimulation by several major haemostatic agonists, including ADP, collagen, thrombin and thromboxane A 2 , and to exacerbate thrombosis in vivo.
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In addition to their role in haemostasis, platelets are recognized to contribute to the immune system, assisting for example in the opsonization and thus clearance of bacteria. [23] [24] [25] [26] [27] Platelets have been shown to secrete cytokines, chemokines and antimicrobial substances such as β-defensin, which help facilitate leukocyte recruitment and assist in the elimination of invading pathogens through the formation of neutrophil extracellular traps (NETs). ] i provides an essential signal that universally links surface receptors to inside-out activation of the main receptor for fibrinogen, GPIIb/IIIa, through activation of the Ca 2þ sensor CalDAG-GEFI. Furthermore, this was not due to a weaker secretory response for FcγRIIa, since antibody-induced ATP release was substantially larger than observed previously for GPVI under the same conditions (►Fig. 5Bi). 10 The large ATP release in combination with efficient autocrine P2X1 activation can explain why FcγRIIa-evoked Ca 2þ increases were insensitive to elevated apyrase compared with a significant ability of this ectonucleotidase to reduce P2X1-stimulated Ca 2þ increases after GPVI engagement. 10 At present, we cannot explain the difference in PGI 2 sensitivity of GPVI versus FcγRIIa secretion and Ca 2þ mobilization other than to speculate that the downstream signalling events are sufficiently distinct in their susceptibility to cyclic AMP or protein kinase A. This may result from the differences in coupling of the external ligand to ITAM domain activation, since the FcγRIIa receptor contains the tyrosine motif within its intracellular tail, whereas GPVI needs to associate with FcRγ to achieve ITAM-induced signalling. The FcγRIIa and FcRγ ITAM domains also differ in structure. A further site for differential cyclic AMP/PKA-dependent inhibition could be at the level of exocytosis. It is becoming clear that different modes of exocytosis exist in platelets, such as single and multigranular fusion events, which could allow specificity amongst individual agonists.
49,50
In conclusion, the present study provides evidence that ATPgated P2X1 channels amplify the intracellular Ca 2þ and aggregation responses in human platelets following stimulation of FcγRIIa receptors. FcγRIIa-induced P2X1 activation was resistant to increased ectonucleotidase activity and persisted following an increase in the presence of the endogenous platelet inhibitor NO, which may allow immune complexes or opsonized bacteria to stimulate platelets in the intact circulation. This raises the possibility that inhibition of P2X1 receptors could represent an antithrombotic target during immune thrombocytopaenia or inflammatory situations such as IE.
What is known about this topic?
• Platelets express FcγRIIa receptors which signal through tyrosine kinases.
• An increase in intracellular Ca 2þ is an essential signalling event during platelet activation; however, the relative importance of different Ca 2þ entry pathways to FcγRIIa receptor signalling is unknown.
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